TOP STORIES

• BUSINESS Generics Showed Strong Growth in 1st Half of FY2013 Despite Lack of New Measures to Promote Their Use
  December 6, 2013

• BUSINESS Takeda Offered 600 M. Yen in Grants to Kyoto University Involved in CASE-J Study, Where Ex-Employee Affiliated
  December 5, 2013

• REGULATORY Would Proposed New Rule for Repricing Long-Listed Drugs Create Winners and Losers? Bill Payers Opposed, Industry Watching Closely
  December 5, 2013

• BUSINESS Ono Joins SGLT-2 Inhibitor Battle via Copromotion Deal with AstraZeneca
  December 4, 2013

• BUSINESS Reimbursement Listing of Ipragliflozin Expected in April; 4 Rival SGLT-2 Inhibitors Seen to Follow Suit 1 Month Later
  December 3, 2013

• BUSINESS Merck to Shed 200 Jobs in Japan by 2015
  December 3, 2013

• BUSINESS GSK Exec Tapped as Takeda’s Next President, 1st Non-Japanese to Lead Japan Juggernaut
  December 2, 2013

• BUSINESS AnGes MG to Resume Collategene Development for Critical Limb Ischemia Treatment: President Yamada
  November 29, 2013

• REGULATORY MHLW Proposes to “Institutionalize” New Drug Premium; Equivocal Wording Draws Fire at CSIMC
  November 28, 2013

• BUSINESS President Hasegawa of Takeda Confident About Achieving Targets in Midterm Growth Strategy; Company to Appoint CIO
  November 28, 2013

• BUSINESS Azilva Tops Physician “Mind Share” Ranking in GP, HP Markets in October: New Survey
  November 27, 2013

• BUSINESS Eisai to Take Over Marketing Rights for Gliadel from Nobelpharma
  November 27, 2013

• ACADEMIA All Clinical Studies Should Follow GCP Requirements: Ex-AZ Chairman Kato
  November 26, 2013

• BUSINESS Farmorubicin Approved for Additional Dosage and Administration for Hepatic Cancer: Pfizer Japan
  November 26, 2013

• BUSINESS AZ Aims to Maintain Presence in Oncology Field Via Partnerships until Launch of New Drugs
  November 25, 2013

• BUSINESS Takeda Deploys Cardiovascular, Diabetes Sales Reps for Comprehensive Detailing Activities for Lifestyle Diseases
  November 22, 2013

• BUSINESS Japan Diovan Sales Down 15.7% in July-September: IMS
  November 22, 2013

• REGULATORY JGA President Opposes 50% Rule for Generics, CSIMC Subcommittee Members Disagree
  November 21, 2013

• BUSINESS Japan Now Part of Global PIII Clinical Study for MLN9708: Takeda
  November 21, 2013

• BUSINESS US Pfizer Plans Simultaneous, Global Filing of Five Biosimilars, Eyes Japan Biosimilar Market Entry
  November 20, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 207
• 208
• 209
• 210
• 211
• 212
• 213
• 214
• 215
• …
• Next ›
• 最終 »